Skip to content

Do Topical Antibiotics Improve Skin Graft Results?

Effects of Topical Neomycin on Skin Graft Outcomes in Rural Bangladesh: a Retrospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07286851
Enrollment
142
Registered
2025-12-16
Start date
2024-12-01
Completion date
2025-08-31
Last updated
2025-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Transplantation, Wounds and Injuries, Antibiotic Prophylaxis Surgery

Keywords

bangladesh, developing countries

Brief summary

The goal of this study is to see if putting antibiotic ointment on a skin graft when the surgery is being done helps prevent the skin graft from getting infected after the operation. The study is looking at all skin grafts done in a rural Bangladesh hospital. The main questions it aims to answer are: Does the antibiotic lower the number of infections that happen? Does the antibiotic make the overall outcome of the skin graft better? Do patients who get the antibiotic need fewer extra surgeries? Researchers will compare the outcomes from patients who had skin grafts before the hospital started applying antibiotic ointment to the outcomes of patients after the hospital began applying antibiotic ointment. Participants who have already had their skin graft treatment completed will have their medical records reviewed by researchers. The outcomes of their treatment will be written down.

Interventions

Topical neomycin was applied at the time of split-thickness skin graft surgery.

Sponsors

LAMB Project
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patient undergoing a split-thickness skin graft at the hospital where research is conducted

Exclusion criteria

* Missing or incomplete medical record

Design outcomes

Primary

MeasureTime frameDescription
Post-operative infection rateMeasured if present at any time during the patient's initial post-operative hospitalization, which averaged 20 days, from time of operation until time of discharge.Whether patients had post-operative infection during their hospitalization, classified as yes or no as defined by any of the following being present: post-operative infection diagnosis written in the patient's medical record, change or increase in antibiotic therapy post-operatively, or the presence of pus documented at the skin graft site.

Secondary

MeasureTime frameDescription
Skin graft takeMeasured at the time of discharge from the patient's initial post-operative hospitalization, which averaged 20 days.Percentage of skin graft that remained intact at the time of discharge, as estimated by the treating surgeon and documented in the patient's record.
Need for operative re-interventionFrom the time of operation until the end of the study period (up to three years for the earliest skin graft patients).Whether patient needed to return to the operating room for additional procedures (such as debridement or repeat skin grafting) for the same wound, classified as yes or no.
Length of stayMeasured at the time of discharge from the patient's initial post-operative hospitalization, which averaged 20 days.Number of days spent in the hospital during the initial post-operative period.
Allergic reactionMeasured if present at any time during the patient's initial post-operative hospitalization, which averaged 20 days, from time of operation until time of discharge.Whether patient had any allergic reaction to neomycin or any other substance documented - categorized as yes or no, based on the new presentation of rash or pruritis.

Countries

Bangladesh

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026